Biodistribution and serologic response in SARS-CoV-2 induced ARDS: A cohort study
SARS-CoV-2 유발 ARDS의 생체분포 및 혈청학적 반응: 코호트 연구
Research Article
[키워드] 30-Day mortality
accompanied
acute respiratory distress
acute respiratory distress syndrome
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
anti-SARS-CoV-2 antibody
Antibody detection
antibody formation
Antiviral treatment
ARDS
binding domain
biodistribution
blood sample
Blood samples
Chain Reaction
cohort study
collected
Concentration
coronavirus
COVID-19
detectable
dialysate
disease severity
distribution
enzyme
enzyme-linked immunosorbent
enzyme-linked immunosorbent assay
high viral load
ICU treatment
IgA antibodies
IgA antibody
IgM
intensive care
intensive care treatment
investigated
majority
Most patient
Most patients
Neutralizing
Neutralizing antibodies
neutralizing antibody
no difference
non-survivor
Non-survivors
oropharyngeal swab
oropharyngeal swabs
Patient
patients
polymerase chain
polymerase chain reaction
positive
Quantitative
RBD
remained
respiratory
respiratory distress
Result
retrospective
reverse transcription
reverse transcription quantitative polymerase chain reaction
RT-qPCR
SARS-CoV-2
SARS-CoV-2 RNA
SARS-CoV-2 viral load
serologic
Serologic response
serologic testing
severe acute respiratory syndrome Coronavirus
severe ARDS
severe corona virus disease
significantly lower
single-center study
suffered
survival
survivor
syndrome
tested
the patient
tissue
tracheal
Tracheal aspirates
Viral
Viral load
Virus Disease
was performed
[DOI] 10.1371/journal.pone.0242917 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pone.0242917 PMC 바로가기 [Article Type] Research Article